Detalles de la búsqueda
1.
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
Clin Infect Dis
; 78(4): 1056-1064, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38051664
2.
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
J Infect Dis
; 228(3): 235-244, 2023 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883903
3.
Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022.
Clin Infect Dis
; 76(6): 1030-1037, 2023 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327388
4.
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
Clin Infect Dis
; 77(4): 547-557, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37255285
5.
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.
MMWR Morb Mortal Wkly Rep
; 72(17): 463-468, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104244
6.
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023.
MMWR Morb Mortal Wkly Rep
; 72(40): 1083-1088, 2023 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796753
7.
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
J Infect Dis
; 226(5): 797-807, 2022 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385875
8.
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
J Infect Dis
; 225(10): 1694-1700, 2022 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932114
9.
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
Clin Infect Dis
; 74(9): 1515-1524, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358310
10.
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
Clin Infect Dis
; 75(Suppl 2): S159-S166, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675695
11.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022.
MMWR Morb Mortal Wkly Rep
; 71(5152): 1625-1630, 2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36580424
12.
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1327-1334, 2022 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264830
13.
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(12): 459-465, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35324878
14.
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
MMWR Morb Mortal Wkly Rep
; 71(4): 118-124, 2022 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085218
15.
Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates.
J Infect Dis
; 224(12): 2035-2042, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34013330
16.
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee.
Clin Infect Dis
; 72(9): 1645-1648, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32628750
17.
Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND).
Clin Infect Dis
; 72(9): 1669-1675, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32974644
18.
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.
Clin Infect Dis
; 73(8): 1459-1468, 2021 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014274
19.
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 674-679, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956782
20.
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
MMWR Morb Mortal Wkly Rep
; 70(38): 1337-1343, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34555004